Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jose F. Muñoz Lozano"'
Autor:
Karen I. Sánchez-Villegas, Jose F. Muñoz-Lozano, Larisa M. Renteria-García, Oscar Vidal-Gutiérrez, Carlos E. Salazar-Mejía
Publikováno v:
Medicina Universitaria, Vol 24, Iss 2 (2022)
Managing recurrent cutaneous squamous cell carcinoma (cSCC) usually requires a multidisciplinary approach. A 74-year-old male presented a nodular lesion on the posterior skull. The lesion was resected, and the specimen was classified as a cSCC. Poste
Externí odkaz:
https://doaj.org/article/f0d55a1d52504124b38c46a97be9433e
Autor:
Cynthia Villarreal-Garza, Alejandra Platas, Melina Miaja, Alan Fonseca, Fernanda Mesa-Chavez, Marisol Garcia-Garcia, Judy-Anne Chapman, Edna A. Lopez-Martinez, Claudia Pineda, Alejandro Mohar, Carmen L. Galvez-Hernandez, Andrea Castro-Sanchez, Bertha-Alejandra Martinez-Cannon, Regina Barragan-Carrillo, Jose F. Muñoz-Lozano, Paul Goss, Juan E. Bargallo-Rocha, Dione Aguilar, Servando Cardona, Mauricio Canavati
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 395-406 (2020)
PURPOSEThe pilot-phase report of the Joven & Fuerte prospective cohort broadly characterizes and assesses the needs of Mexican young women with breast cancer (YWBC).PATIENTS AND METHODSWomen age ≤ 40 years with nonmetastatic primary breast cancer w
Externí odkaz:
https://doaj.org/article/3c800285fb5949ddbeb49be9ef816b31
Autor:
Jose F. Muñoz Lozano, Diana Cristina Pérez Ibave, Estefania Abundis Marquez, Fernando Alcorta Nuñez, Celia B. Gonzalez Alcorta, Carlos Salazar Mejia, Maria Fernanda Noriega, Omar Zayas Villanueva, Victor Oyervides Juarez, Larisa M. Renteria Garcia, Adelina Alcorta Garza, Juan Francisco Gonzalez Guerrero, Valeria Luna, David Hernandez, Rafael Piñeiro Retif, Oscar Vidal Gutiérrez
Publikováno v:
Cancer Research. 83:P1-08
INTRODUCTION Radiotherapy is an area of medicine that is little known by patients and that requires a long time for the doctor to be able to explain and resolve the doubts that arise in the first consultation, which may cause anxiety and low adherenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d53dc860f089381ea4609bd3eb6fe70b
https://doi.org/10.1158/1538-7445.sabcs22-p1-08-03
https://doi.org/10.1158/1538-7445.sabcs22-p1-08-03
Autor:
Jose F. Muñoz Lozano, Omar Zayas Villanueva, Estefania Abundis Marquez, Fernando Alcorta Nuñez, Maria Fernanda Noriega, Carlos Salazar Mejia, Celia B. Gonzalez Alcorta, Diana Cristina Pérez Ibave, Victor Oyervides Juarez, Larisa M. Renteria Garcia, Adelina Alcorta Garza, Juan Francisco Gonzalez Guerrero, David Hernandez, Rafael Piñeiro Retif, Oscar Vidal Gutiérrez
Publikováno v:
Cancer Research. 83:P5-04
Introduction A minority of women with breast cancer in Mexico are diagnosed through a screening program with a low rate of national coverage of about 20%, which translates into late diagnosis and worse outcomes. The detection of high-risk groups thro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb0a5312f79b1d281f58f08792d34292
https://doi.org/10.1158/1538-7445.sabcs22-p5-04-09
https://doi.org/10.1158/1538-7445.sabcs22-p5-04-09
Autor:
Daniela Vazquez-Juarez, Bryan F Vaca-Cartagena, Andrea Becerril-Gaitan, Zuratzi Deneken-Hernandez, Ana S Ferrigno, Antonio Maffuz-Aziz, Edna A Lopez-Martinez, Regina Barragan-Carrillo, Jose F Muñoz-Lozano, Cynthia Villarreal-Garza
Publikováno v:
Cancer Research. 82:P4-05
Background: Choosing the appropriate treatment for patients with early hormone receptor (HR)-positive and HER2-negative breast cancer (BC) remains a challenging process that must balance possible therapy benefits against potential side effects. Recen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46fab3aef0166b3256ca93b52a9be6e6
https://doi.org/10.1158/1538-7445.sabcs21-p4-05-15
https://doi.org/10.1158/1538-7445.sabcs21-p4-05-15